VivaDiag Antigen Rapid test

Rapid test kit description

The new COVID-19 Coronavirus Antibody Detection Kit (Colloidal Gold) is a qualitative membrane-based immunoassay for the detection of COVID-19 antibodies in whole blood, serum, or plasma. This test consists of two components, an IgG component, and an IgM component. In the test region, anti-human IgM and IgG are coated. This kit is used to qualitatively detect the novel coronavirus COVID-19 antibody (IgG / IgM) in human serum, plasma, or whole blood samples. It is used primarily for the auxiliary judgment and dynamic monitoring of novel coronaviruses, and cannot be used as a basis for the diagnosis of novel coronaviruses.

Antibody Detection Kit Parameters (Colloidal Gold)

Composition: Test strip, Assay buffer, Pipette (Sul)

Package instruction:

Each inner box has 30 servings, Volume: 15.5 * 11 * 11 CM, Weight: 0.35 KG

One outer box contains 52 inner boxes, Volume: 65 * 40 * 45CM, Weight: 19.5KG

Packing: paper, plastic bag

Storage temperature: 2 ° C to 30 ° C

Validity period: 12 months

One-Step Test Kit Features

1. Specifications: high sensitivity and specificity, compared to PCR, overall agreement: 98.0%.

2. Quick: the entire testing process only takes 15-20 minutes.

3. Simple: Without any other equipment, the operation is very simple and easy to carry.

4. Flexible: Suitable for serum, plasma, and whole blood samples.

5. High stability: the reagent is stable and can be stored for a long time.

6. For professional in vitro diagnostic use only.

The Novel Coronavirus COVID-19 Antibody Detection Kit (Colloidal Gold) has been compared to a commercial EIA test, and the results indicate high specificity and sensitivity:

LGG Results:

  • Relative sensitivity: 93.0%
  • Relative specificity: 98.7%
  • Accuracy: 98.1%

IgM results:

  • Relative sensitivity: 91.6%
  • Relative specificity: 98.9%
  • Accuracy: 96.7%

How do I understand the results?

  • The reading should show 1 line in region C (control). Purple lines may appear next to the G (IgG) and M (IgM) regions depending on exposure to COVID-19. Faint lines are treated as a positive result.
  • Regions C, G, and M are positive – User was recently infected or re-infected with COVID-19.
  • Regions C and G positive, region M negative: user previously infected with COVID-19.
  • Regions C and M Positive, Region G Negative – User recently infected with COVID-19 for the first time.
  • Region C positive, regions G and M negative: User does not show an immune response to COVID-19.
  • Negative C region, positive or negative G and M regions – The test did not work correctly.

Leave a Reply

Your email address will not be published. Required fields are marked *